HealthQuill Articles by: HealthQuill
Quest Diagnostics, a New Jersey, US-based clinical laboratory company, has started selling the first blood testing kits for detecting Alzheimer’s disease early.
Drugs Health Pharma

Quest Diagnostics unveils direct-to-customer tests for Alzheimer’s 

HQ Team August 1, 2023: Quest Diagnostics, a New Jersey, US-based clinical laboratory company, has started selling the first blood testing kits for

Read More
Harm Reduction Therapeutics’s RiVive has become the second opioid overdose reversal drug the FDA allows without a prescription in the US.
Drugs Health Pharma

USFDA gives nod for second opioid overdose reversal drug ReVive

HQ Team July 30, 2023: A not-for-profit US company, Harm Reduction Therapeutics’s ReVive has been allowed by the FDA to market its opioid

Read More
A Tanzanian child under two years of age has been diagnosed with circulating vaccine-derived poliovirus type 2 (cVDPV2), and the WHO has rated international risk at “high” due to poor surveillance.
Drugs Health Pharma

WHO rates poliovirus detection in Tanzania as “high risk” globally 

HQ Team July 29, 2023: A Tanzanian child under two years of age has been diagnosed with circulating vaccine-derived poliovirus type 2 (cVDPV2),

Read More
Merck & Co., Inc., announced it has met one of the primary goals during a late-stage trial of its breast cancer therapy, Keytruda.
Drugs Health Pharma

Merck & Co meets breast cancer therapy goal in last-stage trials

HQ Team July 29, 2023: Merck & Co., Inc., announced it has met one of the primary goals during a late-stage trial of

Read More
Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for gene therapy projects.
Drugs Health Pharma

Alexion, Pfizer sign $1 billion accord for genomic medicines

HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for

Read More
Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio, according to a company statement
Drugs Health Pharma

Biogen Inc. to buy US-based Reata Pharmaceuticals for $7.3 billion

HQ Team July 29, 2023: Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio,

Read More
Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to the WHO Essential Medicines List.
Drugs Health Pharma

Cancer, multiple sclerosis, Ebola treatments in new WHO Essential Medicines List

HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to

Read More
An unusual rise in cases of Guillain-Barré Syndrome (GBS), a rare neurological disorder, has been reported from Peru, which has declared a state of national health emergency, the WHO stated.
Drugs Health Pharma

Guillain-Barré Syndrome cases rising in Peru, cause unknown

HQ Team July 26, 2023: An unusual rise in cases of Guillain-Barré Syndrome (GBS), a rare neurological disorder, has been reported from Peru,

Read More
Better access to testing and diagnostic services is required to prevent sexually transmitted infections (STI) being acquired by more than one million people every day, the WHO stated.
Drugs Health Pharma

Require access to testing, diagnostic services to control STI: WHO

HQ Team July 26, 2023: Better access to testing and diagnostic services is required to prevent sexually transmitted infections (STI) being acquired by

Read More
At least 2.5 million people died because of drowning in the last decade and 90% of these deaths occurred in low and middle-income nations, according to the WHO.
Health Medical Pharma

Drowning kills 236,000 people, mostly children, every year globally

HQ Team July 25, 2023: At least 2.5 million people died because of drowning in the last decade and 90% of these deaths

Read More